Can a Single Pill Keep you Healthy to 100? A Clinical Trial at RCR Will Soon Find Out.
Rochester Clinical Research is proud to be a part of the cutting-edge research for the investigational drug RTB101, developed by resTORbio. The drug is aimed to arrest aging at a cellular level and has been studied for the past 15 years. This could lead not to a longer life, but a better life. RCR will be enrolling for a study with the RTB101 drug this fall 2019. For those interested in participating, we invite you to call us at 585-288-0890 or click the link to learn more.
Read More
Smallpox Vaccine Needed for Risk of Bioterrorism
Routine vaccinations for smallpox ended 40 years ago after the World Health Organization officially declared global eradication of smallpox. This means the majority of the population is not protected. The threat of bioterrorism and natural re-emergence has prompted the US and countries around the world to prepare an updated vaccine which is more effective and easier to store. RCR is currently on the forefront of developing this vaccine.
Read More
RCR’s State of the Union Address
Each year, Rochester Clinical Research hosts a State of the Union address in March for all of the employees. The meeting recaps the year and looks to future plans that align with our mission – to excel in our field by providing quality care for study volunteers, quality data for sponsors and a quality team-oriented […]
Read More
RCR Highlighted on WHEC News 10: Rochester Innovation
Pat Larrabee, Founder and CEO of RCR was interviewed by News 10 on March 8, 2019. She spoke about the company and the many volunteers who have become Research Heroes in the Greater Rochester area. Click here to watch the clip.
Read More
Lyme Disease Vaccine Needed with Widespread of Disease
Rochester is at the forefront of researching a new Lyme disease vaccine. Rochester, N.Y. – Each year, approximately 30,000 cases of Lyme disease are reported to the CDC and recent estimates using other methods suggest that approximately 300,000 people may get Lyme disease each year in the United States. While antibiotics can help treat […]
Read More
Vaccine Research Study Highlighted on the Seniors Rock Radio Show
On January 15, 2019, the Seniors Rock Show featured Adam Larrabee, President of RCR. Adam spoke about the different vaccine and medication research opportunities we have available to those over the age of 50 in 2019. Listen to the clip here.
Read More
Research study conducted at RCR demonstrates reduction of cardiovascular events for people with type 2 diabetes
A recent research study that was conducted at RCR demonstrates superiority in reduction of cardiovascular events for broad range of people with type 2 diabetes
Read More
Halloween at RCR
The RCR team loves to have fun. Check out our Halloween festivities here. Happy Halloween!
Read More
Help Future Generations, Today
Fall is a favorite season for many people. From pumpkin spice, to everything nice, fall definitely has it’s charm. However, as the seasons change and the weather get colder, more people get sick. While many think it is the cold weather, it is actually because a virus can replicate and spread most effectively when the […]
Read More